Literature DB >> 24640948

The μ-opioid receptor: an electrophysiologist's perspective from the sharp end.

Graeme Henderson1.   

Abstract

UNLABELLED: Morphine, the prototypical opioid analgesic drug, produces its behavioural effects primarily through activation of μ-opioid receptors expressed in neurones of the central and peripheral nervous systems. This perspective provides a historical view of how, over the past 40 years, the use of electrophysiological recording techniques has helped to reveal the molecular mechanisms by which acute and chronic activation of μ-opioid receptors by morphine and other opioid drugs modify neuronal function. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  electrophysiology; locus coeruleus; morphine; opioid

Mesh:

Substances:

Year:  2014        PMID: 24640948      PMCID: PMC4292943          DOI: 10.1111/bph.12633

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.

Authors:  Jamie McPherson; Guadalupe Rivero; Myma Baptist; Javier Llorente; Suleiman Al-Sabah; Cornelius Krasel; William L Dewey; Chris P Bailey; Elizabeth M Rosethorne; Steven J Charlton; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2010-07-20       Impact factor: 4.436

2.  Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid.

Authors:  L Chen; L Y Huang
Journal:  Neuron       Date:  1991-08       Impact factor: 17.173

3.  Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.

Authors:  Chad E Groer; Cullen L Schmid; Alex M Jaeger; Laura M Bohn
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

4.  Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro.

Authors:  C W Vaughan; M J Christie
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

5.  Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.

Authors:  Elizabeth A Johnson; Sue Oldfield; Ellen Braksator; Ana Gonzalez-Cuello; Daniel Couch; Kellie J Hall; Stuart J Mundell; Chris P Bailey; Eamonn Kelly; Graeme Henderson
Journal:  Mol Pharmacol       Date:  2006-05-08       Impact factor: 4.436

6.  Enkephalin opens potassium channels on mammalian central neurones.

Authors:  J T Williams; T M Egan; R A North
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

7.  Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons.

Authors:  Vu C Dang; Ian A Napier; MacDonald J Christie
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

8.  mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.

Authors:  Veronica A Alvarez; Seksiri Arttamangkul; Vu Dang; Abdallah Salem; Jennifer L Whistler; Mark Von Zastrow; David K Grandy; John T Williams
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Multiple inhibitory G-protein-coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons.

Authors:  Reagan L Pennock; Matthew S Dicken; Shane T Hentges
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

10.  Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.

Authors:  C P Bailey; S Oldfield; J Llorente; C J Caunt; A G Teschemacher; L Roberts; C A McArdle; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

View more
  2 in total

1.  Themed section.

Authors:  M J Christie; M Connor; J R Traynor
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

2.  Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation.

Authors:  Yinbing Pan; Xiaodi Sun; Lai Jiang; Liang Hu; Hong Kong; Yuan Han; Cheng Qian; Chao Song; Yanning Qian; Wentao Liu
Journal:  J Neuroinflammation       Date:  2016-11-17       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.